$PFHO

PACIFIC HEALTH CARE ORGANIZATION INC

CIK:0001138476|SEC Filings

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues
Revenues	$ 1,774,651	$ 1,726,541	$ 3,272,355	$ 3,545,355
Expenses
Salaries and wages	674,363	743,000	1,307,715	1,432,482
Professional fees	174,488	142,710	360,878	377,840
Insurance	79,908	89,685	163,022	172,293
Outsource service fees	230,144	179,590	445,219	353,140
Data maintenance	59,076	62,067	85,370	198,182
General and administrative	187,276	205,930	368,069	393,440
Total expenses	1,405,255	1,422,982	2,730,273	2,927,377
Income from operations	369,396	303,559	542,082	617,978
Other income (expense)
Other income	0	419,801	0	419,801
Interest income	94,229	172,315	189,414	266,059
Interest expense	0	0	0	(1,522)
Total other income, net	94,229	592,116	189,414	684,338
Income before taxes	463,625	895,675	731,496	1,302,316
Income tax provision	136,617	258,768	210,819	372,746
Net income	$ 327,008	$ 636,907	$ 520,677	$ 929,570
Basic earnings per share:
Net Income per share amount (in Dollars per share)	$ 0.03	$ 0.05	$ 0.04	$ 0.07
Weighted average shares outstanding, basic (in Shares)	12,800,000	12,800,000	12,800,000	12,800,000
Fully diluted earnings per share:
Net Income per share amount (in Dollars per share)	$ 0.03	$ 0.05	$ 0.04	$ 0.07
Weighted average shares outstanding, diluted (in Shares)	12,816,000	12,816,000	12,816,000	12,816,000
HCO
Revenues
Revenues	$ 302,737	$ 320,387	$ 488,963	$ 814,516
MPN
Revenues
Revenues	146,040	170,215	300,974	329,220
Medical Bill Review
Revenues
Revenues	140,233	84,332	259,268	212,909
Utilization Review
Revenues
Revenues	616,105	531,335	1,153,702	1,026,377
Medical Case Management
Revenues
Revenues	563,336	617,572	1,063,198	1,133,883
Other
Revenues
Revenues	$ 6,200	$ 2,700	$ 6,250	$ 28,450

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from Operating Activities
Net income	$ 520,677	$ 929,570
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	10,528	13,258
Loss on disposal of property and office equipment	451	0
Provision for credit losses	1,362	(1,759)
Noncash interest on investments	(41,231)	(40,952)
Deferred taxes	(1,547)	(2,567)
Changes in operating assets and liabilities
Accounts receivable	(325,848)	(61,369)
Other assets	(584)	(382)
Prepaid expenses	(65,656)	(38,437)
Income tax receivable	(2,805)	0
Accounts payable	4,474	289
Accrued expenses	102,849	(82,626)
Income tax payable	17,256	60,646
Unearned revenue	2,867	10,167
Net cash provided by operating activities	222,793	785,838
Cash flows from Investing Activities
Proceeds from investments	10,042,817	9,033,761
Purchase of investments	(10,190,230)	(9,689,787)
Purchase of property and office equipment	(4,524)	(8,510)
Net cash used in investing activities	(151,937)	(664,536)
Cash flows from Financing Activities
Payment of cash dividends	0	(625)
Payments made on insurance financing agreement	0	(35,305)
Net cash provided by (used in) financing activities	0	(35,930)
Net increase in cash and cash equivalents	70,856	85,372
Cash and cash equivalents at beginning of period	2,168,808	2,070,476
Cash and cash equivalents at end of period	2,239,664	2,155,848
Supplemental Cash Flow Information
Interest	0	1,522
Income taxes	$ 197,915	$ 319,000

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 2,239,664	$ 2,168,808
Investments	10,231,461	10,042,817
Accounts receivable, net	1,330,173	1,005,687
Prepaid expenses	223,114	157,458
Income tax receivable	16,078	13,273
Total current assets	14,040,490	13,388,043
Long-term Assets
Property and equipment, net	45,269	51,724
Deferred tax assets	17,734	16,187
Other assets	8,076	7,492
Total long-term assets	71,079	75,403
Total Assets	14,111,569	13,463,446
Current Liabilities
Accounts payable	232,499	228,025
Accrued expenses	229,876	127,027
Income tax payable	17,256	0
Unearned revenue	36,411	33,544
Total current liabilities	516,042	388,596
Commitments and Contingencies
Stockholders’ Equity
Convertible preferred stock, 5,000,000 shares authorized at $0.001 par value of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding at June 30, 2026 and December 31, 2025	16	16
Common stock, $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding at June 30, 2026 and December 31, 2025	12,800	12,800
Additional paid-in capital	416,057	416,057
Retained earnings	13,166,654	12,645,977
Total stockholders’ equity	13,595,527	13,074,850
Total Liabilities and Stockholders’ Equity	$ 14,111,569	$ 13,463,446